Page last updated: 2024-08-23

diltiazem and Lung Diseases

diltiazem has been researched along with Lung Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aquilante, CL; Fish, DN; Kiser, TH; Schoeppler, KE; Zamora, MR1
Karlsberg, RP1
Boden, WE; Gibson, RS; Hansen, JF; Messerli, FH; Schechtman, KB1
Berman, BA; Ross, RN1
McGoon, MD; Shub, C; Vlietstra, RE1

Reviews

3 review(s) available for diltiazem and Lung Diseases

ArticleYear
Heart rate-lowering calcium antagonists in hypertensive post-myocardial infarction patients.
    Journal of hypertension, 2001, Volume: 19, Issue:5

    Topics: Aged; Calcium Channel Blockers; Diltiazem; Female; Heart Rate; Humans; Hypertension; Lung Diseases; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Verapamil

2001
Treating coexisting cardiovascular and pulmonary disease with calcium antagonists.
    Annals of allergy, 1986, Volume: 56, Issue:3

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Asthma, Exercise-Induced; Bronchial Spasm; Calcium; Calcium Channel Blockers; Cardiovascular Diseases; Constipation; Diltiazem; Headache; Heart Conduction System; Humans; Ion Channels; Lung Diseases; Lung Diseases, Obstructive; Nifedipine; Verapamil

1986
Selection of optimal drug therapy for the patient with angina pectoris.
    Mayo Clinic proceedings, 1985, Volume: 60, Issue:8

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diltiazem; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Heart Rate; Heart Ventricles; Humans; Hypertension; Kidney Diseases; Lung Diseases; Myocardium; Nifedipine; Nitrates; Physical Exertion; Receptors, Adrenergic, beta; Systole; Vascular Diseases; Vasodilation; Verapamil

1985

Other Studies

2 other study(ies) available for diltiazem and Lung Diseases

ArticleYear
The impact of genetic polymorphisms, diltiazem, and demographic variables on everolimus trough concentrations in lung transplant recipients.
    Clinical transplantation, 2014, Volume: 28, Issue:5

    Topics: Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; Biomarkers; Cross-Sectional Studies; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Demography; Diltiazem; Everolimus; Female; Follow-Up Studies; Gene Expression Regulation; Genotype; Humans; Immunosuppressive Agents; Lung Diseases; Lung Transplantation; Male; Middle Aged; Polymorphism, Genetic; Pregnane X Receptor; Prognosis; Receptors, Steroid; Sirolimus; Tissue Distribution; Transplant Recipients; Vasodilator Agents

2014
Welcome--the calcium channel blockers.
    Chest, 1981, Volume: 80, Issue:6

    Topics: Adrenergic beta-Antagonists; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Cardiovascular Diseases; Coronary Disease; Diltiazem; Humans; Ion Channels; Lung Diseases; Nifedipine; Tachycardia; Verapamil

1981